ALI HEALTH News

Big Bank Rating | Dahua Jixian: Lowering Ali Health's Target Price to HK$4 to Maintain “Buy” Rating

Gelonghui FinanceApr 8 10:22

Ali Health (0241.HK) 2HFY24 Performance Forecast: High base effect puts pressure on revenue growth in the short term

華泰證券Mar 29 21:01

Ali Health (0241.HK): Steadily improving operating efficiency and acquiring parent group's healthcare advertising and marketing business

海通國際Dec 14, 2023 15:06

Huachuang Securities: Maintaining Ali Health (00241) “Recommended” Rating Target Price HK$5.7

Zhitong FinanceDec 11, 2023 11:38

Alibaba Health (00241.HK): Steady growth in the business sector and continuous improvement in profitability

華創證券Dec 8, 2023 19:37

Bank Ratings｜Bank of America: Maintaining Ali Health's “Buy” Rating Target Price Lowered to HK$6.4

Gelonghui FinanceDec 6, 2023 10:17

Citi: Maintaining Ali Health (00241) “Buy/High Risk” Rating Target Price Reduced to HK$8

Zhitong FinanceDec 1, 2023 13:38

Bank Ratings｜Macquarie: Maintaining Ali Health's “neutral” rating, the target price was raised to HK$4.7

Gelonghui FinanceDec 1, 2023 11:03

Ali Health (0241.HK): Strengthening collaboration within the group to improve the platform business ecosystem

華泰證券Nov 30, 2023 16:06

Bank Ratings｜Daimo: Maintaining Ali Health's “holdings reduction” rating with a target price of HK$5

Gelonghui FinanceNov 29, 2023 10:25

Ali Health (00241.HK): The steady development of the business sector has received another injection of capital from major shareholders

國金證券Nov 29, 2023 00:00

Bank Ratings｜CITIC Leon: Maintaining Ali Health's “Buy” Rating and Raising Target Price to HK$6.4

Gelonghui FinanceNov 15, 2023 11:13

Ali Health (00241.HK) Follow-up Review: Exploring the Closed Loop of Digital Health Management “Examination+Medical+Medicine”

中信證券Nov 14, 2023 18:02

Ali Health (00241.HK) In-depth Report: Pharmaceutical E-commerce Positions Stabilize, Internet Healthcare Injects New Momentum

東北證券Nov 13, 2023 00:00

Bank Rating｜UBS: Lowers Alibaba Health's target price to HK$5 and rated “neutral”

Gelonghui FinanceOct 25, 2023 11:22

Ali Health (00241.HK): Revenue continued to grow rapidly in the post-epidemic era

國信證券Oct 22, 2023 00:00

Bank Ratings | Lyon: First “buy” rating of Alibaba Health with a target price of HK$6.8

Gelonghui FinanceJun 29, 2023 10:31

Changes in Hong Kong stocks | Alibaba Health (00241)'s target price and revenue forecast were lowered by Goldman Sachs Citi after falling more than 4% again

Zhitong FinanceMay 31, 2023 11:34

Big Bank Ratings | Goldman Sachs: Lowered Ali Health's Target Price to HK$6.4 to Neutral Rating

Gelonghui FinanceMay 30, 2023 14:36

Alibaba Health (00241.HK): Achieving profit potential to reverse losses throughout the year

華創證券May 10, 2023 07:37